[144] Adient plc SEC Filing

Rhea-AI Filing Summary

Adient plc submitted a Form 144 disclosing a proposed sale of 12,000 common shares acquired as restricted stock units on 11/18/2022. The shares are to be sold through Oppenheimer & Co. Inc. on the NYSE with an approximate aggregate market value of $271,119.00 and total shares outstanding listed as 81,245,928. The filing shows no securities sold by the reporting person in the past three months. The notice includes the signer’s representation that they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Planned sale disclosed: 12,000 common shares announced for sale, providing market transparency
• Broker and exchange identified: Oppenheimer & Co. on the NYSE with an aggregate market value of $271,119.00
• Acquisition method disclosed: Shares were acquired as RSUs on 11/18/2022, with payment recorded on the same date

Negative

• Filer identifiers missing: CIK and submission contact fields are empty in the provided content
• Limited context on seller: The filing does not include additional narrative about the reason or any trading plan dates beyond the attestation

Insights

Securities Analyst

TL;DR: Routine insider notice: 12,000 Adient shares proposed for sale via Oppenheimer, disclosed under Rule 144.

The Form 144 is a standard regulatory disclosure identifying a proposed sale of 12,000 common shares with an aggregate market value of $271,119. It specifies the broker (Oppenheimer & Co.) and the target exchange (NYSE), and notes the shares were acquired as RSUs on 11/18/2022. The filing reports no sales in the past three months and includes the customary representation regarding undisclosed material adverse information. This filing is procedural and provides transparency about an intended insider sale.

Corporate Governance Expert

TL;DR: Disclosure follows Rule 144 mechanics; identifies acquisition type, broker, and outstanding shares but omits filer contact details.

The notice documents key compliance elements: the nature of acquisition (RSU), acquisition and payment dates (11/18/2022), and the planned sale date (08/07/2025). It confirms the broker and exchange. However, fields for filer CIK and contact information appear blank in the provided content, which limits immediate on-file identification of the reporting person. The form includes the required signer attestation about material information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Oppenheimer & Co Inc 85 Broad Street New York NY 10004	12000	271119.00	81245928	08/07/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	11/18/2022	RSU	Issuer			12000	11/18/2022	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Adient (ADNT) Form 144 disclose?

The filing discloses a proposed sale of 12,000 common shares through Oppenheimer & Co. on the NYSE with an aggregate value of $271,119.00.

When were the shares acquired that are being sold under Form 144?

The shares were acquired as RSUs on 11/18/2022, and the payment date is recorded as 11/18/2022.

What is the approximate date of the planned sale in the Form 144 for ADNT?

The filing lists the approximate date of sale as 08/07/2025.

How many shares outstanding does the filing list for Adient?

The Form 144 reports 81,245,928 shares outstanding.

Were any securities sold in the past three months by the reporting person?

The filing indicates Nothing to Report for securities sold during the past three months.

Does the Form 144 include a broker name and address?

Yes. The broker is listed as Oppenheimer & Co. Inc, 85 Broad Street, New York, NY 10004.